arrow
D

Daniëlle J. Vugts

amsterdam umc location vrije universiteit amsterdam
H指数:46
被引数:6,444

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

In-human assessment of target engagement and blockade of radiolabeled BI 765063, an anti-SIRPα antibody

在人中评估放射性标记的BI 765063(一种抗-SIRPα抗体)的靶点结合和阻断作用

2026-08-130
OAAI
Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trial

RO7300490的安全性及活性评估:一种靶向纤维细胞活化蛋白的双特异性CD40激动剂,用于晚期实体瘤患者的单臂、多中心、首次人体、Ⅰ期临床试验

2026-05-010
PRE
[89Zr]bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic NF2-related schwannomatosis: a study protocol for a phase II single centre, prospective, feasibility trial

[89Zr]贝伐珠单抗PET/CT成像在预测症状性NF2相关神经鞘瘤病患者贝伐珠单抗治疗效果中的应用:一项针对单中心、前瞻性、可行性II期试验的研究方案

2026-04-080
OA
89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism

89Zr-mAb的摄取解释需要使用校正了抗体分解代谢的组织与血浆比率。

2025-09-260
OA
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative,-Low, and-Positive Metastatic Breast Cancer

在HER2-Negative,低和阳性转移性乳腺癌中通过HER2 PET鉴定的全身HER2异质性

2024-09-052
PRE